Evidence map›Paper›PMID 26185031›Full record

ArticleJournal of magnetic resonance imaging : JMRI2016

Feasibility of a reduced field-of-view diffusion-weighted (rFOV) sequence in assessment of myometrial invasion in patients with clinical FIGO stage I endometrial cancer.

Priya Bhosale, Jingfei Ma, Revathy Iyer, Preetha Ramalingam, Wei Wei, Pamela Soliman, Michael Frumovitz, Vikas Kundra

Abstract read
In one paragraph

Article in Journal of magnetic resonance imaging : JMRI, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.

  1. ESGO/ESTRO/ESP Guidelines for the management of patients with endometrial carcinoma.Virchows Archiv : an international journal of pathology · 2021
    Guideline
  2. Article
  3. Endometrial Cancer: A Daily Clinical Practice Guide for Radiologists.Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Evaluating Myometrial Invasion in Endometrial Cancer: Comparison of Reduced Field-of-view Diffusion-weighted Imaging and Dynamic Contrast-enhanced MR Imaging.Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine · 2018
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Priya BhosaleDepartment of Diagnostic Radiology, the University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, USA.
Jingfei MaDepartment of Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, USA.
Revathy IyerDepartment of Diagnostic Radiology, the University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, USA.
Preetha RamalingamDepartment of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, USA.
Wei WeiDepartment of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, USA.
Pamela SolimanDepartment of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, USA.
Michael FrumovitzDepartment of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, USA.
Vikas KundraDepartment of Diagnostic Radiology, the University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, USA.
The University of Texas MD Anderson Cancer Center · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
NCI NIH HHS P30 CA016672NCI NIH HHS P30CA016672
6 · The paper itself

Abstract

purposeTo compare the clinical usefulness of reduced field-of-view diffusion-weighted imaging (rFOV) with other imaging techniques in determining the depth of myometrial invasion (DMI) in endometrial cancer. MATERIALS AND

methodsIn this prospective study we reviewed 3T magnetic resonance images of 51 patients with clinical Stage I endometrial cancer who underwent total abdominal hysterectomy with bilateral salphingoopherectomy within 3 days after imaging. rFOV with apparent diffusion coefficient reconstruction was obtained in three standard planes followed by sagittal T2 -weighted (T2 WI) images and 3D dynamic T1 -weighted and contrast-enhanced imaging (DCE MRI). Two radiologists with expertise in imaging gynecologic cancers evaluated images independently. The DMI was recorded on imaging and correlated with surgical pathology results. Sensitivity, specificity, positive predictive value, negative predictive value, and accuracy for DMI were calculated (<50% vs. >50%).

resultsCompared with sagittal T2 WI + DCE MRI, rFOV imaging yielded greater specificity (82.2% vs. 90.0%, positive predictive value (42.8% vs. 60.0%), and accuracy (84.0% vs. 92%) for DMI determined by reader 1 and greater the sensitivity (83.3% vs. 100%) for DMI determined by reader 2. The error of measurement of DMI as a continuous variable in millimeters did not differ significantly between the rFOV and pathology results (P < 0.21). However, there was a statistically significant difference for the DMI measured on the dynamic sequence. The DMI on DCE was greater than that seen on pathology at P = 0.02.

conclusionrFOV can be used to assess DMI in clinical Stage I endometrial cancer.

Indexed as

AdultAgedDiffusion Magnetic Resonance ImagingEndometrial NeoplasmsFeasibility StudiesFemaleHumansMiddle AgedMyometriumNeoplasm InvasivenessProspective StudiesReproducibility of ResultsSensitivity and SpecificitySeverity of Illness IndexDCE MRIdepth of myometrial invasiondiffusionMRIrFOVStage I endometrial cancerT2 weighted

Identifiers

PMID26185031
PMCPMC4715803
OpenAlexW2140074800

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.